CS243484B2 - Method of 7 beta-(z(-2-)2-aminothiazol-4-yl)-2-oxyimino/acetamido)-3-cepham-4-carboxyl acids' derivatives preparation - Google Patents

Method of 7 beta-(z(-2-)2-aminothiazol-4-yl)-2-oxyimino/acetamido)-3-cepham-4-carboxyl acids' derivatives preparation Download PDF

Info

Publication number
CS243484B2
CS243484B2 CS831964A CS196483A CS243484B2 CS 243484 B2 CS243484 B2 CS 243484B2 CS 831964 A CS831964 A CS 831964A CS 196483 A CS196483 A CS 196483A CS 243484 B2 CS243484 B2 CS 243484B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
mixture
compound
acid
group
Prior art date
Application number
CS831964A
Other languages
Czech (cs)
English (en)
Other versions
CS196483A2 (en
Inventor
Toyonari Oine
Hiroshi Sugano
Yoshihisa Yamada
Totaro Yamaguchi
Satoshi Ohshima
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of CS196483A2 publication Critical patent/CS196483A2/cs
Publication of CS243484B2 publication Critical patent/CS243484B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CS831964A 1982-08-07 1983-08-04 Method of 7 beta-(z(-2-)2-aminothiazol-4-yl)-2-oxyimino/acetamido)-3-cepham-4-carboxyl acids' derivatives preparation CS243484B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8222823 1982-08-07

Publications (2)

Publication Number Publication Date
CS196483A2 CS196483A2 (en) 1985-08-22
CS243484B2 true CS243484B2 (en) 1986-06-12

Family

ID=10532181

Family Applications (2)

Application Number Title Priority Date Filing Date
CS831964A CS243484B2 (en) 1982-08-07 1983-08-04 Method of 7 beta-(z(-2-)2-aminothiazol-4-yl)-2-oxyimino/acetamido)-3-cepham-4-carboxyl acids' derivatives preparation
CS835791A CS236798B2 (en) 1982-08-07 1983-08-04 Processing of cefalosporine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS835791A CS236798B2 (en) 1982-08-07 1983-08-04 Processing of cefalosporine

Country Status (23)

Country Link
US (4) US4598075A (ru)
EP (2) EP0101265B1 (ru)
JP (3) JPS5951292A (ru)
KR (1) KR870001440B1 (ru)
AT (2) ATE35413T1 (ru)
AU (1) AU562248B2 (ru)
BG (3) BG37838A3 (ru)
CA (1) CA1231940A (ru)
CS (2) CS243484B2 (ru)
DD (1) DD210053A5 (ru)
DE (2) DE3377213D1 (ru)
DK (2) DK358983A (ru)
ES (3) ES524775A0 (ru)
FI (1) FI74972C (ru)
GR (1) GR78864B (ru)
IE (1) IE55406B1 (ru)
IL (1) IL69246A (ru)
NO (1) NO161068C (ru)
PH (1) PH18498A (ru)
PL (2) PL140023B1 (ru)
PT (1) PT77166B (ru)
SU (2) SU1227116A3 (ru)
ZA (1) ZA835411B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS60132983A (ja) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体及びその製法
JPS6178792A (ja) * 1984-09-26 1986-04-22 Yamanouchi Pharmaceut Co Ltd ７−〔α−（２−アミノ−４−チアゾリル）−α−（４−オキソ−２−アゼチジニル置換イミノ）アセトアミド〕−３−置換メチル−Δ↑３−セフエム−４−カルボン酸およびその製造法
JPS6185392A (ja) * 1984-10-03 1986-04-30 Tanabe Seiyaku Co Ltd セフアロスポリン化合物の新規製法
JPS61143379A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
JPS61143381A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd 光学活性チアゾ−ル酢酸誘導体の製法
JPS61143380A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
CA1263399A (en) * 1984-12-19 1989-11-28 Hoffmann-La Roche Limited Process for the manufacture of aminothiazole acetic acid derivatives
JPS61171464A (ja) * 1985-01-23 1986-08-02 Dai Ichi Seiyaku Co Ltd オキシイミノ酪酸誘導体の製法
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
AT389701B (de) * 1987-10-08 1990-01-25 Tanabe Seiyaku Co Neue cephalosporinverbindungen und diese enthaltende pharmazeutische zusammensetzungen
JP4773154B2 (ja) * 2005-07-29 2011-09-14 小澤物産株式会社 レバー式カップリング

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
IE44888B1 (en) * 1976-03-09 1982-05-05 Fujisawa Pharmaceutical Co 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation theroef
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
FR2384782A1 (fr) * 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
SE448379B (sv) * 1978-03-31 1987-02-16 Roussel Uclaf O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
EP0009548B1 (en) * 1978-07-17 1985-01-16 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
GB2028305A (en) * 1978-08-03 1980-03-05 Hoechst Ag Cephem derivatives and processes for their manufacture
GB2061276B (en) * 1979-10-25 1983-05-25 Squibb & Sons Inc Imidazole and tetrazole derivatives of 7-((2-amino-4-thiazolyl)-oximino)cephalosporins
US4271157A (en) * 1980-02-28 1981-06-02 E. R. Squibb & Sons, Inc. Imidazole derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS59155391A (ja) * 1983-02-22 1984-09-04 Tanabe Seiyaku Co Ltd 新規セファロスポリン誘導体

Also Published As

Publication number Publication date
DK361587A (da) 1987-07-10
ATE54450T1 (de) 1990-07-15
NO832828L (no) 1984-02-08
DK358983D0 (da) 1983-08-05
FI832770A0 (fi) 1983-08-02
DE3381734D1 (de) 1990-08-16
BG42835A3 (en) 1988-02-15
JPH0145473B2 (ru) 1989-10-03
KR840005816A (ko) 1984-11-19
PL249964A1 (en) 1985-05-07
JPS62294615A (ja) 1987-12-22
EP0245619A1 (en) 1987-11-19
SU1324586A3 (ru) 1987-07-15
ES8506707A1 (es) 1985-08-01
NO161068C (no) 1989-06-28
JPS5951292A (ja) 1984-03-24
US4742174A (en) 1988-05-03
JPH0246588B2 (ru) 1990-10-16
ES8502121A1 (es) 1984-12-16
ZA835411B (en) 1984-03-28
PT77166A (en) 1983-09-01
PT77166B (pt) 1986-01-28
DE3377213D1 (en) 1988-08-04
FI74972B (fi) 1987-12-31
IL69246A0 (en) 1983-11-30
ES535281A0 (es) 1985-12-16
DD210053A5 (de) 1984-05-30
ATE35413T1 (de) 1988-07-15
JPH0360803B2 (ru) 1991-09-17
EP0245619B1 (en) 1990-07-11
AU1710483A (en) 1984-02-09
CS196483A2 (en) 1985-08-22
ES531296A0 (es) 1985-08-01
ES8603496A1 (es) 1985-12-16
US4727071A (en) 1988-02-23
GR78864B (ru) 1984-10-02
JPS62294681A (ja) 1987-12-22
BG37838A3 (en) 1985-08-15
DK358983A (da) 1984-02-08
NO161068B (no) 1989-03-20
BG40967A3 (en) 1987-03-14
SU1227116A3 (ru) 1986-04-23
EP0101265A2 (en) 1984-02-22
PL140023B1 (en) 1987-03-31
AU562248B2 (en) 1987-06-04
PL243329A1 (en) 1985-02-13
EP0101265B1 (en) 1988-06-29
FI832770A (fi) 1984-02-08
IE55406B1 (en) 1990-09-12
ES524775A0 (es) 1984-12-16
DK361587D0 (da) 1987-07-10
EP0101265A3 (en) 1985-04-10
IL69246A (en) 1986-07-31
CS236798B2 (en) 1985-05-15
US4598154A (en) 1986-07-01
FI74972C (fi) 1988-04-11
PL139932B1 (en) 1987-03-31
KR870001440B1 (ko) 1987-08-06
IE831648L (en) 1984-02-07
US4598075A (en) 1986-07-01
PH18498A (en) 1985-08-02
CA1231940A (en) 1988-01-26

Similar Documents

Publication Publication Date Title
EP0251299B1 (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
CS243484B2 (en) Method of 7 beta-(z(-2-)2-aminothiazol-4-yl)-2-oxyimino/acetamido)-3-cepham-4-carboxyl acids' derivatives preparation
DK159156B (da) Analogifremgangsmaade til fremstilling af (2-(2-aminothiazol-4-yl)-2-(0-substitueret)-oxyiminoacetamido)-7-cephalosporan-syre og fysiologisk acceptable salte deraf
US4067978A (en) Pharmaceutical compositions of α-amino-α-(ureidophenyl)acetamidocephalosporins
US4760060A (en) 3-heteroaralkylthio carbacephem compounds and antibacterial pharmaceutical composition
DK161832B (da) Analogifremgangsmaade til fremstilling af 1-sulfo-2-azetidinonderivater eller farmaceutisk acceptable salte eller estere deraf
HUT53653A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising such compounds as active ingredient
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
FI73689C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara pyridincefalosporiner.
GB2083461A (en) 7-beta-(alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-acetamido)-3-((1,2,3-thiadiazol-5-ylthio)methyl)-3-cephem-4-carboxylic acid and c1-c6 alkyl derivatives thereof
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
EP0630899A1 (en) Cephem compound, process for producing the same, and medicine containing the same
EP0000272B1 (en) 7-acylamino-3-substituted-3-cephem-4-carboxylic acids, processes for their preparation and pharmaceutical compositions containing them
BE1007544A3 (fr) Derives de thioalkylthiocarbacephalosporines.
CS236491B2 (en) Method of cephalosporines preparation
SE448238B (sv) Nya 1-oxadetiacefalosporinderivat, forfarande for framstellning derav, antibakteriell komposition innehallande dem samt anvendning av dem for att hemma bakterietillvext in vitro
EP0081971A2 (en) Novel cephalosporin compound and process for preparing the same
US4160829A (en) Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
EP0000285B1 (en) 7-acylamino-3-((3-(carboxymethyl) thio-1 h-1,2,4-triazol-5-yl) thiomethyl)-3-cephem-4-carboxylic acid derivatives, processes for their preparation and compositions containing them
JPS59152385A (ja) ヒドロキサム酸系セフアロスポリン誘導体
KR870001441B1 (ko) 세팔로스포린 화합물의 제조방법
KR20020068508A (ko) 7-아실아미노-3-헤테로아릴티오-3-세펨 카르복실산 항생제및 그의 전구약물
JP2002187896A (ja) ホスホノ基を有するセフェム化合物
US20100130509A1 (en) Novel antibiotics
HU191661B (en) Process for preparing 7beta-acylamido-3-cefem-4-carboxylic acid derivatives and pharmaceutical preparations comprising the same as active substance